AEPGX
Price
$61.54
Change
-$0.71 (-1.14%)
Updated
Jul 24 closing price
Net Assets
140.66B
WCMIX
Price
$27.68
Change
-$0.13 (-0.47%)
Updated
Jul 24 closing price
Net Assets
21.68B
Interact to see
Advertisement

AEPGX vs WCMIX

AEPGX vs WCMIX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. WCMIX commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Hold and WCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 141B vs. WCMIX (21.7B). AEPGX pays higher dividends than WCMIX: AEPGX (2.53) vs WCMIX (0.71). AEPGX was incepted earlier than WCMIX: AEPGX (42 years) vs WCMIX (15 years). WCMIX (1.05) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 50.00 vs. WCMIX (23.00). AEPGX has a lower initial minimum investment than WCMIX: AEPGX (250) vs WCMIX (100000). WCMIX annual gain was more profitable for investors over the last year : 4.58 vs. AEPGX (2.41). WCMIX return over 5 years is better than : 0.12 vs. AEPGX (-6.41).
AEPGXWCMIXAEPGX / WCMIX
Total Expense Ratio0.831.0579%
Annual Report Gross Expense Ratio0.831.0579%
Fund Existence42 years15 years-
Gain YTD1.70211.77714%
Front Load6%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets141B21.7B650%
Annual Yield % from dividends2.530.71357%
Returns for 1 year2.414.5853%
Returns for 3 years16.3724.2967%
Returns for 5 years-6.410.12-5,548%
Returns for 10 years44.13117.4838%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNTX25.600.11
+0.43%
MFS Equity Income R3
FCADX60.49N/A
N/A
Fidelity Advisor International Discv C
IGFAX5.39N/A
N/A
VY® Morgan Stanley Global Franchise A
OBSIX39.15N/A
N/A
Oberweis Small-Cap Opportunities Instl
BRSTX16.69-0.01
-0.06%
MFS Blended Research Small Cap Eq R3